Table 4

Cancer mortality and estimated exposure to styrene, International Agency for Research on Cancer cohort of reinforced plastics workers exposed to styrene, 1945–1991

LungOesophagusPancreasProstate
RR*95% CIAICRR95% CIAICRR95% CIAICRR95% CIAIC
Cumulative styrene exposure (100 ppm-years)
 0-year lag1.020.99 to 1.0530991.060.97 to 1.16298.61.030.97 to 1.10612.41.030.96 to 1.10538.5
 10-year lag1.030.99 to 1.0630991.080.98 to 1.19298.21.030.96 to 1.11612.61.000.92 to 1.10539.2
 20-year lag1.000.91 to 1.0931001.161.03 to 1.31296.81.010.84 to 1.22613.20.970.76 to 1.23539.2
Mean styrene exposure (100 ppm)
 0-year lag0.980.79 to 1.2231002.441.11 to 5.36294.81.891.17 to 3.06606.41.260.76 to 2.11538.3
 10-year lag0.970.80 to 1.1831002.531.30 to 4.90293.01.310.82 to 2.10611.91.030.64 to 1.68539.2
 20-year lag0.810.59 to 1.1231013.361.74 to 6.49290.91.140.57 to 2.28613.11.070.55 to 2.10539.2
  • *RR per 100 ppm-year or 100 ppm. RRs adjusted as follows: NHL, age, calendar decade, sex; lung cancer, age, sex, country; oesophageal cancer, pancreatic cancer: age; prostate cancer: age, country.

  • AIC, Akaike information criterion; NHL, non-Hodgkin’s lymphoma; RR, rate ratio.